New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the presentation of new data at the 2021 San...

Related Keywords

Canada ,United States ,San Antonio ,Texas ,America ,Kevin Kalinsky ,Stephanie Spanos ,Federico Maiardi ,Megan Jones ,Exchange Commission ,Sciences Corp ,Genomic Health Inc ,Facebook ,Sciences On Twitter Exactsciences ,Sciences Corporation ,New England Journal ,Recurrence Score ,Princess Margaret Trial ,Exact Sciences ,Poster Sessions ,Spotlight Poster Discussions ,North East England ,Using Oncotype ,Pan Cancer Tissue ,Genomic Health ,Risk Factors ,Annual Report ,Quarterly Reports ,Latin America ,Oral Presentation ,San Antonio Breast Cancer Symposium ,Breast Can Res Treat ,Ann Surg ,Exact Sciences Corp ,